Caris Life Sciences, Inc.
CAI
$38.39
-$0.09-0.23%
NASDAQ
| 06/30/2025 | 03/31/2025 | 06/30/2024 | |||
|---|---|---|---|---|---|
| Net Income | -71.79M | -102.58M | -66.19M | ||
| Total Depreciation and Amortization | 6.41M | 7.05M | 11.61M | ||
| Total Amortization of Deferred Charges | 7.76M | 1.95M | 1.73M | ||
| Total Other Non-Cash Items | 66.35M | 48.93M | -5.97M | ||
| Change in Net Operating Assets | -1.44M | 13.32M | -4.12M | ||
| Cash from Operations | 7.29M | -31.34M | -62.93M | ||
| Capital Expenditure | -1.39M | -2.69M | -2.59M | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | -- | -- | 0.00 | ||
| Cash from Investing | -1.39M | -2.69M | -2.59M | ||
| Total Debt Issued | 27.87M | -- | 0.00 | ||
| Total Debt Repaid | -22.00K | -22.00K | -30.00K | ||
| Issuance of Common Stock | 529.65M | 1.43M | 393.00K | ||
| Repurchase of Common Stock | -1.66M | -22.00K | -- | ||
| Issuance of Preferred Stock | 121.24M | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | 4.33M | -105.00K | -492.00K | ||
| Cash from Financing | 681.40M | 1.29M | -129.00K | ||
| Foreign Exchange rate Adjustments | 93.00K | 4.00K | 12.00K | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | 687.40M | -32.74M | -65.63M | ||